Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

NCT02425137 is registered in ClinicalTrials.gov with TTY Biopharm as lead sponsor.

NCT NCT02425137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
Lead sponsor
TTY Biopharm
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2017
Enrollment
51 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced biliary tract cancer(btc)